528 related articles for article (PubMed ID: 19031183)
1. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
Park BK; Kim CK
Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
[TBL] [Abstract][Full Text] [Related]
2. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
3. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
6. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
Marshall FF
J Urol; 2005 Nov; 174(5):1782. PubMed ID: 16217284
[No Abstract] [Full Text] [Related]
8. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
[TBL] [Abstract][Full Text] [Related]
10. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
[TBL] [Abstract][Full Text] [Related]
11. Is radiofrequency ablation safe for solitary kidneys?
Jacobsohn KM; Ahrar K; Wood CG; Matin SF
Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax.
Ahrar K; Matin S; Wallace MJ; Gupta S; Hicks ME
AJR Am J Roentgenol; 2005 Jul; 185(1):86-8. PubMed ID: 15972404
[TBL] [Abstract][Full Text] [Related]
13. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up.
Arzola J; Baughman SM; Hernandez J; Bishoff JT
Urology; 2006 Nov; 68(5):983-7. PubMed ID: 17095059
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates.
Herrera LJ; Fernando HC; Perry Y; Gooding WE; Buenaventura PO; Christie NA; Luketich JD
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):929-37. PubMed ID: 12698158
[TBL] [Abstract][Full Text] [Related]
16. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.
Shibata T; Shibata T; Maetani Y; Kubo T; Itoh K; Togashi K; Hiraoka M
J Vasc Interv Radiol; 2004 Nov; 15(11):1323-7. PubMed ID: 15525754
[TBL] [Abstract][Full Text] [Related]
17. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected].
Nakamura T; Matsumine A; Yamakado K; Matsubara T; Takaki H; Nakatsuka A; Takeda K; Abo D; Shimizu T; Uchida A
Cancer; 2009 Aug; 115(16):3774-81. PubMed ID: 19514086
[TBL] [Abstract][Full Text] [Related]
18. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results.
Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A
Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.
Pautler SE; Pavlovich CP; Mikityansky I; Drachenberg DE; Choyke PL; Linehan WM; Wood BJ; Walther MM
Can J Urol; 2001 Aug; 8(4):1330-3. PubMed ID: 11564277
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency thermal ablation in the treatment of lung malignancies.
Gadaleta C; Catino A; Mattioli V
In Vivo; 2006; 20(6A):765-7. PubMed ID: 17203764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
